Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

Fertility supplement market by Ingredient (Natural and Synthetic/Blend of Natural & Synthetic), Product (Capsules, Tablets, Soft Gels, Powders, and Liquids) and End User (Men and Women): Global Opportunity Analysis and Industry Forecast, 2020–2030

  • ALL4676856
  • 236 Pages
  • September 2021
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
The global fertility supplements market generated $1,754.00 million in 2020 and is projected to reach $3,652.50 million by 2030, growing at a CAGR of 7.50% from 2021 to 2030.

Fertility supplements are the chemical supplements or drugs that enhance the fertility levels in males and females. It contain hormones, antioxidants and other ingredients that can boost fertility. Currently, certain fertility supplements contain herbal ingredients and are more in demand in the fertility supplements market.

In males, the fertility supplements help to increase the sperm count, motility and zinc boosts testosterone levels. And, in females, the supplements help to elevate the estrogen levels. Some common fertility supplements are Acetyl L-carnitine, Acetyl L-carnitine, Folic acid, Vitamins, Minerals and others. These fertility supplements have advantages such as it builds hormones that further supports the reproductive procedure. With the help of these supplements the ovulation cycle is managed, and contains nutrients and minerals which are essential for the development of fetus.

The global fertility supplements market is expected to witness a substantial growth in the future, owing to high incidence of infertility cases and emerging trend of delayed pregnancies among women. In addition, the prevalence of smoking is higher in developed countries than in emerging economies. Even fertility treatments such as IVF is not helpful in conceiving for smoking women, which has prompted fertility manufacturers to look for ingredients that can eliminate the effects of smoking on fertility. This factor is anticipated to create growth opportunities for fertility supplement manufacturers over the forecast period.

Furthermore, there is growing adoption of herbal medicines (botanicals) owing to the increasing concerns about the harmful impacts associated with the traditional pharmaceutical drugs is poised to generate new opportunities for the fertility supplements manufacturers, leading to the growth of the fertility supplements market. Various public initiatives to raise awareness regarding advancements in fertility supplements among consumers and its superior technology have helped the industry gain a further boost. However, the lack of awareness among the population of low-income economies is anticipated to restrain the growth of the global fertility supplements market.

According to the American Society for Reproductive Medicine, in the U.S., approximately 35% and 30% of men and women of reproductive age smoke cigarettes. The prevalence of smoking is higher in developed countries than in emerging economies. Even fertility treatments such as IVF may not be helpful in conceiving for smoking women, which has prompted fertility manufacturers to look for ingredients that can eliminate the effects of smoking on fertility. This factor is anticipated to create growth opportunities for the fertility supplement manufacturers over the forecast period.

Increasing importance of food products such as avocados, olive oil, whole grains, and high fat dairy products used in increasing fertility is expected to amplify the scope of functional food and beverages in the near future resulting in hindering the overall growth.

The global fertility supplements market is classified into ingredient, product, end user, and region. By ingredient, the market is divided into natural, and synthetic/blend of natural & synthetic. By product, it is categorized into capsules, tablets, soft gels, powders, and liquids. By end user, the market is segmented into men and women. By region, the market is analyzed across the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, France, Spain, Italy, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

• The study provides an in-depth analysis of the fertility supplements market, and the current trends and future estimations to elucidate the imminent investment pockets.

• It presents a quantitative analysis of the market from 2020 to 2030 to enable stakeholders to capitalize on the prevailing market opportunities.

• Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.

• Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Ingredient

• Natural

• Synthetic/Blend of Natural & Synthetic

By Product

• Capsules

• Tablets

• Soft Gels

• Powders

• Liquids

By End User

• Men

• Women

By Region

North America

• U.S.

• Canada

• Mexico

Europe

• Germany

• France

• UK

• Italy

• Spain

• Rest of Europe

Asia-Pacific

• Japan

• China

• India

• Australia

• Rest of Asia-Pacific

LAMEA

• Brazil

• Saudi Arabia

• South Africa

• Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

• Fairhaven Health

• Coast Science

• Lenus Pharma GesmbH

• Active Bio Life Science GmbH

• Orthomol

• Exeltis USA, Inc.

• PregPrep LLC

• Bionova

• TTK HealthCare Ltd.

• Fertility Nutraceuticals LLC

CHAPTER 1:INTRODUCTION

1.1.Report description

1.2.Key benefits for stakeholders

1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study

2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five force analysis

3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Continuous decline in fertility rates

3.4.1.2.Delayed pregnancies in women

3.4.2.Restraints

3.4.2.1.Technological advancements with respect to fertility treatment restrain the market growth

3.4.3.Opportunity

3.4.3.1.Rising demand for natural ingredients

3.5.COVID-19 impact on the fertility supplements market

3.5.1.Overview

3.5.2.Impact analysis

CHAPTER 4:FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS

4.1.Overview

4.1.1.Market size and forecast

4.2.Natural

4.2.1.Key market trends, growth factors, and opportunities

4.2.2.Market size and forecast

4.2.3.Market analysis, by country

4.3.Synthetic and blend

4.3.1.Key market trends, growth factors, and opportunities

4.3.2.Market size and forecast

4.3.3.Market analysis, by country

CHAPTER 5:FERTILITY SUPPLEMENTS MARKET, BY PRODUCT

5.1.Overview

5.1.1.Market size and forecast

5.2.Capsules

5.2.1.Market size and forecast

5.2.2.Market analysis, by country

5.3.Tablets

5.3.1.Market size and forecast

5.3.2.Market analysis, by country

5.4.Soft Gels

5.4.1.Market size and forecast

5.4.2.Market analysis, by country

5.5.Powders

5.5.1.Market size and forecast

5.5.2.Market analysis, by country

5.6.Liquids

5.6.1.Market size and forecast

5.6.2.Market analysis, by country

CHAPTER 6:FERTILITY SUPPLEMENTS MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Men

6.2.1.Market size and forecast

6.2.2.Market analysis, by country

6.2.2.1.Market size and forecast, by product

6.3.Women

6.3.1.Market size and forecast

6.3.2.Market analysis, by country

6.3.2.1.Market size and forecast, by product

CHAPTER 7:FERTILITY SUPPLEMENTS MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities

7.2.2.Market size and forecast, by country

7.2.3.Market size and forecast, By ingredients

7.2.4.Market size and forecast, By product

7.2.5.Market size and forecast, by end user

7.2.5.1.U.S.

7.2.5.2.U.S. market size and forecast, By ingredients

7.2.5.3.U.S. Market size and forecast, By product

7.2.5.4.U.S. Market size and forecast, by end user

7.2.5.5.Canada

7.2.5.6.Market size and forecast, By ingredients

7.2.5.7.Canada Market size and forecast, By product

7.2.5.8.Canada Market size and forecast, by end user

7.2.5.9.Mexico

7.2.5.10.Market size and forecast, By ingredients

7.2.5.11.Mexico Market size and forecast, By product

7.2.5.12.Mexico Market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities

7.3.2.Europe Market size and forecast, by country

7.3.3.Europe Market size and forecast, By ingredients

7.3.4.Europe market size and forecast, By product

7.3.5.Europe market size and forecast, by end user

7.3.5.1.Germany

7.3.5.2.Market size and forecast, By ingredients

7.3.5.3.Germany market size and forecast, By product

7.3.5.4.Germany market size and forecast, by end user

7.3.5.5.France

7.3.5.6.Market size and forecast, By ingredients

7.3.5.7.France market size and forecast, By product

7.3.5.8.France market size and forecast, by end user

7.3.5.9.UK

7.3.5.10.Market size and forecast, By ingredients

7.3.5.11.UK market size and forecast, By product

7.3.5.12.UK market size and forecast, by end user

7.3.5.13.Italy

7.3.5.14.Market size and forecast, By ingredients

7.3.5.15.Italy Market size and forecast, By product

7.3.5.16.Italy market size and forecast, by end user

7.3.5.17.Spain

7.3.5.18.Market size and forecast, By ingredients

7.3.5.19.Spain Market size and forecast, By product

7.3.5.20.Spain Market size and forecast, by end user

7.3.5.21.Rest of Europe

7.3.5.22.Market size and forecast, By ingredients

7.3.5.23.Rest of Europe market size and forecast, By product

7.3.5.24.Rest of Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities

7.4.2.Market size and forecast, by country

7.4.3.Asia-Pacific market size and forecast, By ingredients

7.4.4.Asia-Pacific market size and forecast, By product

7.4.5.Asia-Pacific market size and forecast, by end user

7.4.5.1.Japan

7.4.5.2.Market size and forecast, By ingredients

7.4.5.3.Japan market size and forecast, By product

7.4.5.4.Japan market size and forecast, by end user

7.4.5.5.India

7.4.5.6.Market size and forecast, By ingredients

7.4.5.7.India Market size and forecast, By product

7.4.5.8.India market size and forecast, by end user

7.4.5.9.China

7.4.5.10.market size and forecast, By ingredients

7.4.5.11.China Market size and forecast, By product

7.4.5.12.China Market size and forecast, by end user

7.4.5.13.Australia

7.4.5.14.Market size and forecast, By ingredients

7.4.5.15.Australia market size and forecast, By product

7.4.5.16.Australia Market size and forecast, by end user

7.4.5.17.South Korea

7.4.5.18.Market size and forecast, By ingredients

7.4.5.19.South Korea market size and forecast, By product

7.4.5.20.South Korea market size and forecast, by end user

7.4.5.21.Rest of Asia-Pacific

7.4.5.22.Market size and forecast, By ingredients

7.4.5.23.Rest of Asia-Pacific Market size and forecast, By product

7.4.5.24.Rest of Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities

7.5.2.Market size and forecast, by country

7.5.3.LAMEA market size and forecast, By ingredients

7.5.4.LAMEA market size and forecast, By product

7.5.5.LAMEA market size and forecast, by end user

7.5.5.1.Brazil

7.5.5.2.Market size and forecast, By ingredients

7.5.5.3.Brazil market size and forecast, By product

7.5.5.4.Brazil market size and forecast, by end user

7.5.5.5.Saudi Arabia

7.5.5.6.Market size and forecast, by ingredients

7.5.5.7.Saudi Arabia market size and forecast, By product

7.5.5.8.Saudi Arabia market size and forecast, by end user

7.5.5.9.South Africa

7.5.5.10.market size and forecast, by ingredients

7.5.5.11.South Africa market size and forecast, By product

7.5.5.12.South Africa market size and forecast, by end user

7.5.5.13.Rest of LAMEA

7.5.5.14.market size and forecast, by ingredients

7.5.5.15.Rest of LAMEA market size and forecast, By product

7.5.5.16.Rest of LAMEA market size and forecast, by end user

LIST OF TABLES

TABLE 01.FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020–2030 ($MILLION)

TABLE 02.FERTILITY SUPPLEMENTS MARKET FOR NATURAL, BY REGION, 2020–2030 ($MILLION)

TABLE 03.FERTILITY SUPPLEMENTS MARKET FOR SYNTHETIC AND BLEND, BY REGION, 2020–2030 ($MILLION)

TABLE 04.FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 05.FERTILITY SUPPLEMENTS MARKET FOR CAPSULES, BY REGION, 2020-2030 ($MILLION)

TABLE 06.FERTILITY SUPPLEMENTS MARKET FOR TABLETS, BY REGION, 2020-2030 ($MILLION)

TABLE 07.FERTILITY SUPPLEMENTS MARKET FOR SOFT GELS, BY REGION, 2020-2030 ($MILLION)

TABLE 08.FERTILITY SUPPLEMENTS MARKET FOR POWDERS, BY REGION, 2020-2030 ($MILLION)

TABLE 09.FERTILITY SUPPLEMENTS MARKET FOR LIQUIDS, BY REGION, 2020-2030 ($MILLION)

TABLE 10.FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 11.FERTILITY SUPPLEMENTS MARKET FOR MEN, BY REGION, 2020-2030 ($MILLION)

TABLE 12.FERTILITY SUPPLEMENTS MARKET FOR MEN, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 13.FERTILITY SUPPLEMENTS MARKET FOR WOMEN, BY REGION, 2020-2030 ($MILLION)

TABLE 14.FERTILITY SUPPLEMENTS MARKET FOR WOMEN, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 15.FERTILITY SUPPLEMENTS MARKET, BY REGION, 2020-2030 ($MILLION)

TABLE 16.NORTH AMERICA FERTILITY SUPPLEMENTS MARKET, BY COUNTRY, 2020-2030 ($MILLION)

TABLE 17.NORTH AMERICA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 18.NORTH AMERICA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 19.NORTH AMERICA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 20.U.S. FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 21.U.S. FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 22.U.S. FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 23.CANADA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 24.CANADA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 25.CANADA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 26.MEXICO FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 27.MEXICO FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 28.MEXICO FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 29.EUROPE FERTILITY SUPPLEMENTS MARKET, BY COUNTRY, 2020-2030 ($MILLION)

TABLE 30.EUROPE FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 31.EUROPE FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 32.EUROPE FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 33.GERMANY FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 34.GERMANY FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 35.GERMANY FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 36.FRANCE FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 37.FRANCE FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 38.FRANCE FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 39.UK FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 40.UK FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 41.UK FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 42.ITALY FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 43.ITALY FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 44.ITALY FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 45.SPAIN FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 46.SPAIN FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 47.SPAIN FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 48.REST OF EUROPE FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 49.REST OF EUROPE FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 50.REST OF EUROPE FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 51.ASIA-PACIFIC FERTILITY SUPPLEMENTS MARKET, BY COUNTRY, 2020-2030 ($MILLION)

TABLE 52.ASIA-PACIFIC FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 53.ASIA-PACIFIC FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 54.ASIA-PACIFIC FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 55.JAPAN FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 56.JAPAN FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 57.JAPAN FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 58.INDIA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 59.INDIA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 60.INDIA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 61.CHINA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 62.CHINA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 63.CHINA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 64.AUSTRALIA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 65.AUSTRALIA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 66.AUSTRALIA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 67.SOUTH KOREA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 68.SOUTH KOREA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 69.SOUTH KOREA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 70.REST OF ASIA-PACIFIC FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 71.REST OF ASIA-PACIFIC FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 72.REST OF ASIA-PACIFIC FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 73.LAMEA FERTILITY SUPPLEMENTS MARKET, BY COUNTRY, 2020-2030 ($MILLION)

TABLE 74.LAMEA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 75.LAMEA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 76.LAMEA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 77.BRAZIL FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 78.BRAZIL FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 79.BRAZIL FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 80.SAUDI ARABIA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 81.SAUDI ARABIA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 82.SAUDI ARABIA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 83.SOUTH AFRICA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 84.SOUTH AFRICA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 85.SOUTH AFRICA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 86.REST OF LAMEA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)

TABLE 87.REST OF LAMEA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 88.REST OF LAMEA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2017-2021 UK Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.

Summary

This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...

  • Publish Date: February 7, 2017
  • $750
2017-2021 US Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.

Summary

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...

  • Publish Date: February 7, 2017
  • $750
2017-2021 Immunohematology and Infectious Disease Screening Market: Competitive Analysis of Major Suppliers and Emerging Market Entrants

This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Con...

  • Publish Date: February 7, 2017
  • $750